Sort
46,585 grants matching “heart failure”
Temporal effects of CD8 T-cells post-MI
$504,681Kristine Y Deleon-Pennell · Medical University Of South Carolina · R01 · FY2025 · HL
ARRHYTHMOGENIC REMODELING IN HUMAN HEART FAILURE
$504,647Igor R Efimov · Washington University · R01 · FY2012 · HL
Reducing heart failure re-admissions by enhancing sleep apnea treatment adherence
$504,612Eric Heil · Rightcare Solutions, Inc. · R44 · FY2015 · HL
Role of Meis1 in Regulation of Cardiomyocyte Proliferation
$504,559Hesham Sadek · Ut Southwestern Medical Center · R01 · FY2015 · HL
CENTER FOR AMERICAN INDIAN AND ALASKA NATIVE DIABETES TRANSLATION RESEARCH
$504,450Spero M Manson · University Of Colorado Denver · P30 · FY2019 · DK
Contributions of Myeloid Metabolism to Diastolic Dysfunction
$504,422Edward Benjamin Thorp · Northwestern University At Chicago · R01 · FY2024 · HL
Transcriptional regulation of cardiac pathological remodeling by REV-ERBα
$504,378Lilei Zhang · Baylor College Of Medicine · R01 · FY2019 · HL
Immortal DNA Strand and Cardiac Stem Cell Aging
$504,249Piero Anversa · Brigham And Women'S Hospital · R01 · FY2014 · AG
Mapping Disease Pathways for Biliary Atresia
$504,232Rakesh K. Sindhi · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
The Atrial Fibrillation - Factor Identification to Risk Modification Study in HD
$504,227Wolfgang Christoph Winkelmayer · Stanford University · R01 · FY2012 · DK
Interdisciplinary Training Program in Cardiovascular Disease
$504,194Dudley K. Strickland · University Of Maryland Baltimore · T32 · FY2017 · HL
Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus
$504,185Matthew A Allison · University Of California, San Diego · R01 · FY2024 · HL
Risk Factors for Fractures Among the Elderly
$504,184Shreyasee Amin · Mayo Clinic Rochester · P01 · FY2019 · AG
CA+2 AND NA+ TRANSPORT AND ARRHYTHMIAS IN HEART FAILURE
$504,148Loyola University Chicago · R01 · FY2002 · HL
MHC Array T Cell Assay System for Monitoring Immune Status in Type 1 Diabetes
$504,097Ernest Fitch Guignon · Ciencia, Inc. · R43 · FY2007 · DK
A Test for Salt Sensitivity in People with Essential Hypertension
$504,066Stephen L Carrithers · Sequela · R44 · FY2008 · DK
Staphylococcus aureus Infections in Ventricular Assist Device Patients
$504,066Franklin D Lowy · Columbia University Health Sciences · P50 · FY2007 · HL
Resolution of inflammation in healing myocardial infarcts
$504,048Nikolaos G Frangogiannis · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · HL
Multi-scale systems analysis of blood pressure control and hypertension
$503,995Daniel A Beard · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue
$503,928Jeffrey S Chamberlain · University Of Washington · R01 · FY2016 · HL
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue
$503,928Jeffrey S Chamberlain · University Of Washington · R01 · FY2018 · HL
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue
$503,928Jeffrey S Chamberlain · University Of Washington · R01 · FY2015 · HL
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue
$503,928Jeffrey S Chamberlain · University Of Washington · R01 · FY2017 · HL
Neurovascular Consequences of Non-Pulsatile Flow from Left Ventricular Assist Devices
$503,911Joshua Zebadiah Willey · Columbia University Health Sciences · R01 · FY2025 · NS
Genetics of lipoprotein metabolism and CVD in CKD
$503,898Daniel James Rader · University Of Pennsylvania · R01 · FY2011 · HL